Form D · Biotechnology

Accipiter Biosciences Inc.

Seattle, WA · CIK 0001973963

Offering snapshot reported Jul 28, 2026 · SEC filing

Reported sold
$10.5M
Offering amount: $10.5M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 21, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2026Initial$10,492,778No comparison9SEC filing
Sep 24, 2025Amendment$13,598,492$5,678,495vs May 28, 202415SEC filing
May 28, 2024Initial$7,919,997No comparison13SEC filing
May 2, 2023Initial$650,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-592356

Source: Form D, filed Jul 28, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jose Antonio Mesa Cejudo Director
Hector Arano Director, Executive, Promoter
William Arthur Director, Executive, Promoter
Matthew Bick Director, Executive, Promoter
William Canestaro Executive
Javier Castellanos Director, Executive, Promoter
Hector De Jesus Rincon Arano Director, Executive, Promoter
Heather Gorham Director
Jiaping Gu Director
Heather Redman Director
Randall Schatzman Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1616 Eastlake Ave E. Suite 208
Seattle, WA, 98102
Phone: 212-472-6343